Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT02559856
Eligibility Criteria:
Inclusion Criteria:
* Confirmed newly diagnosed acute VTE (proximal lower extremity deep vein thrombosis and segmental or greater pulmonary embolism)
* Age ≥ 18 years old
* Written informed consent
Exclusion Criteria:
* Any contraindication for anticoagulation such as active bleeding
* Clinically significant liver disease or alanine aminotransferase (ALT) levels ≥ 3 times the upper limit of normal range
* Creatinine clearance \< 30 ml/min calculated with the Cockcroft-Gault formula (29)
* Known allergies to either apixaban or rivaroxaban
* Pregnancy
* Use of contraindicated medications with apixaban or rivaroxaban
* Active malignancy in the last 6 months (excluding localized skin malignancy)
* No private insurance coverage for the study drug or not willing to pay for study drug
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02559856
Study Brief:
Protocol Section:
NCT02559856